Generic (Lorlatinib) Lornedx 25

Inquire / Price
Inquire Now Link

Poster
  • Details
  • Description
  • Packaging Size
    30T/Bottle
  • Strength
    25mg
  • Compositon
    Lorlatinnib
  • Treatment
    ALK positive metastatic NSCLC
  • Form
    Tablet
  • Brand
    Lornedx
  • Quantity Unit
    25mg*30T/bottle
  • Manufacturer
    DAXIONG Pharma,LAOs PDR

Lorlatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults that has spread to other parts of the body. Lorlatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply.

Non-small Cell Lung Cancer

Indicated for metastatic non-small cell lung cancer (NSCLC) in patients whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test

100 mg PO qDay with or without food

Continue until disease progression or unacceptable toxicity

Dosage Modifications

Dosage modifications for adverse reactions

  • First dose reduction: 75 mg qDay
  • Second dose reduction: 50 mg qDay
  • Unable to tolerate 50 mg qDay: Permanently discontinue

Link

Poster

Top